Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden

BACKGROUND: Vaccine effectiveness against COVID-19 beyond 6 months remains incompletely understood. We aimed to investigate the effectiveness of COVID-19 vaccination against the risk of infection, hospitalisation, and death during the first 9 months after vaccination for the total population of Swed...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordström, Peter, Ballin, Marcel, Nordström, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816388/
https://www.ncbi.nlm.nih.gov/pubmed/35131043
http://dx.doi.org/10.1016/S0140-6736(22)00089-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816388/
https://www.ncbi.nlm.nih.gov/pubmed/35131043
http://dx.doi.org/10.1016/S0140-6736(22)00089-7

Ejemplares similares